Seminar Series: Microfluidic assays to model trauma and transfusion medicine

In the US, over 30,000 people die each year due to traumatic injury that could have been saved if they had received more timely or appropriate care. Further exacerbating poor clinical outcomes is a unique acute coagulopathy induced by injury itself, which increases mortality risk by 400%. Improving outcomes for these patients is a complex problem as there are multiple contributing factors to each individual’s pathophysiology. In addition, the treatment for bleeding in trauma is to transfuse blood products, which also come with their own distinct mechanistic changes due to both material surface interactions and extended storage outside of the body. This seminar will focus on the use of microfluidics to better understand traumatic coagulopathy and its treatments, including blood product function, and will also discuss philosophies and approaches surrounding multidisciplinary clinically translational research.

This lecture is part of the CBR lecture series. Held on Wednesdays from 1-2pm PT, CBR seminars feature insightful scientific talks, with speakers from a range of clinical, industry and academic backgrounds.

Presented by

Dr. Susan Shea
Assistant Professor of Surgery and Bioengineering
Associate Director, Trauma and Transfusion Medicine Research Center
University of Pittsburgh

Hosted by Dr. Jay Kizhakkedathu

Registration

For information about CBR Seminar series events, visit the CBR website: CBR Seminars | Centre for Blood Research (ubc.ca). To receive Zoom access details for CBR Seminar series events, contact Kaitlyn Chuong (kaitlyn.chuong@ubc.ca).